Literature DB >> 2358315

DNA fingerprinting of the intestinal parasite Giardia duodenalis with the M13 phage genome.

P Upcroft1, R Mitchell, P F Boreham.   

Abstract

A DNA fingerprint procedure has been established for the intestinal parasite, Giardia duodenalis. This permits the identification of individual strains from both human and animal sources. Analysis of strain movement, resurgence and variation is now possible. The fingerprint probe is based on the tandem repetitive sequence found in bacteriophage M13 which hybridizes to a set of hypervariable polymorphic minisatellite sequences found in higher eukaryotes. This probe recognizes a weakly homologous set of hypervariable regions in the Giardia genome to provide a DNA fingerprint comparable to those seen in higher eukaryotes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358315     DOI: 10.1016/0020-7519(90)90146-e

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  5 in total

Review 1.  WITHDRAWN: Drugs for treating giardiasis.

Authors:  J O M Zaat; T H G Mank; W J J Assendelft
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 2.  DNA fingerprinting of medically important microorganisms by use of PCR.

Authors:  A van Belkum
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

3.  Investigation of human giardiasis by karyotype analysis.

Authors:  S H Korman; S M Le Blancq; R J Deckelbaum; L H Van der Ploeg
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

4.  Genotyping Naegleria spp. and Naegleria fowleri isolates by interrepeat polymerase chain reaction.

Authors:  A van Belkum; J De Jonckheere; W G Quint
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

5.  Detection of variable DNA repeats in diverse eukaryotic microorganisms by a single set of polymerase chain reaction primers.

Authors:  D E Riley; M Samadpour; J N Krieger
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.